Does CARBOCYSTEINE Cause Product dose omission issue? 88 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Product dose omission issue have been filed in association with CARBOCYSTEINE. This represents 12.6% of all adverse event reports for CARBOCYSTEINE.
88
Reports of Product dose omission issue with CARBOCYSTEINE
12.6%
of all CARBOCYSTEINE reports
32
Deaths
85
Hospitalizations
How Dangerous Is Product dose omission issue From CARBOCYSTEINE?
Of the 88 reports, 32 (36.4%) resulted in death, 85 (96.6%) required hospitalization, and 30 (34.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARBOCYSTEINE. However, 88 reports have been filed with the FAERS database.
What Other Side Effects Does CARBOCYSTEINE Cause?
Lower respiratory tract infection (110)
Rash (107)
Off label use (94)
Pulmonary pain (90)
Arthropathy (83)
Condition aggravated (82)
Abdominal discomfort (79)
Overdose (78)
Drug abuse (77)
Intentional product misuse (77)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which CARBOCYSTEINE Alternatives Have Lower Product dose omission issue Risk?
CARBOCYSTEINE vs CARBOMER
CARBOCYSTEINE vs CARBON DIOXIDE
CARBOCYSTEINE vs CARBON MONOXIDE
CARBOCYSTEINE vs CARBOPLATIN
CARBOCYSTEINE vs CARBOPROST TROMETHAMINE